Biological markers of amyloid β-related mechanisms in Alzheimer's disease
Top Cited Papers
- 30 June 2010
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 223 (2), 334-346
- https://doi.org/10.1016/j.expneurol.2009.09.024
Abstract
No abstract availableKeywords
This publication has 204 references indexed in Scilit:
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer DiseaseArchives of Neurology, 2008
- Amyloid-β immunisation for Alzheimer's diseaseThe Lancet Neurology, 2008
- Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1 -null miceProceedings of the National Academy of Sciences, 2008
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairmentNeurobiology of Aging, 2007
- Clearance of amyloid-β by circulating lipoprotein receptorsNature Medicine, 2007
- Lipocalin-type prostaglandin D synthase/β-trace is a major amyloid β-chaperone in human cerebrospinal fluidProceedings of the National Academy of Sciences, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Conservation evaluation and phylogenetic diversityBiological Conservation, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991